Andreas D. Ebert

ORCID: 0000-0002-4471-131X · 60 papers in corpus
2006
·doi:10.1515/9783110199925.12
2006
·doi:10.1515/9783110199925.76
2006
·doi:10.1515/9783110199925
review 2005
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2005.04.017

The medical treatment of endometriosis needs to be optimized. Therapeutic management strategies for endometriosis-associated pain or recurrent disease are primarily aimed at downregulating ovarian function or antagonizing the effect of estr…

other 2005
Fertility and sterility ·doi:10.1016/j.fertnstert.2004.11.038

OBJECTIVE: To investigate the expression of oxytocin receptor (OTR) in peritoneal and ovarian endometriotic lesions. DESIGN: Retrospective nonrandomized study. SETTING: University hospital endometriosis research center. PATIENT(S): Preme…

2004
·doi:10.1007/s10304-004-0085-2
other 2003
The American journal of surgical pathology ·doi:10.1097/00000478-200311000-00009

The present study aimed to investigate oxytocin receptor (OTR) expression in the normal uterus, and particularly in uterine smooth muscle tumors and endometrial stromal sarcomas (ESSs) because these tumors can be difficult to distinguish. T…

2002
·doi:10.1007/s00129-002-1159-7
case-report 2002
Zentralblatt für Gynäkologie ·doi:10.1055/s-2002-38912

Endometriosis affects a 10 % of women during their reproductive years. Unequoral statistics concerning the incidence of adenomyosis are not available although a combined occurrence of both diseases is found in a 20 % of cases. The risk that…

case-report 2002
Archives of gynecology and obstetrics ·doi:10.1007/s00404-002-0435-z

Danazol, an inhibitor of pituitary gonadotropin with weak androgenic effect, is currently being used for the treatment of endometriosis. In contrast to other C17 alkylated anabolic steroids, it has been rarely associated with the occurrence…